Free Trial

Accuray (ARAY) Competitors

Accuray logo
$1.36 -0.05 (-3.55%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$1.36 0.00 (0.00%)
As of 07/11/2025 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, BSX, SYK, and MDT

Should you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

Accuray vs. Its Competitors

Orthofix Medical (NASDAQ:OFIX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

Orthofix Medical has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Accuray has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.

Accuray has lower revenue, but higher earnings than Orthofix Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$799.49M0.54-$126M-$3.69-2.99
Accuray$446.55M0.31-$15.55MN/AN/A

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 1.3% of Orthofix Medical shares are held by company insiders. Comparatively, 4.2% of Accuray shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Accuray has a net margin of 0.14% compared to Orthofix Medical's net margin of -17.78%. Accuray's return on equity of 1.43% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-17.78% -28.15% -16.51%
Accuray 0.14%1.43%0.14%

Orthofix Medical presently has a consensus price target of $21.50, suggesting a potential upside of 94.57%. Given Orthofix Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Orthofix Medical is more favorable than Accuray.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
Accuray
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Orthofix Medical had 1 more articles in the media than Accuray. MarketBeat recorded 5 mentions for Orthofix Medical and 4 mentions for Accuray. Orthofix Medical's average media sentiment score of 1.67 beat Accuray's score of 1.02 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Accuray
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Orthofix Medical beats Accuray on 9 of the 15 factors compared between the two stocks.

Get Accuray News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARAY vs. The Competition

MetricAccurayMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$140.10M$6.73B$5.56B$9.11B
Dividend YieldN/A1.28%5.06%4.01%
P/E RatioN/A26.3028.2620.26
Price / Sales0.3185.55437.10166.10
Price / CashN/A20.3337.1257.67
Price / Book3.024.648.045.49
Net Income-$15.55M$174.76M$3.19B$250.45M
7 Day Performance-4.49%-1.00%3.62%4.79%
1 Month Performance11.48%0.99%5.98%9.59%
1 Year Performance-30.96%5.27%29.39%16.41%

Accuray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARAY
Accuray
2.7762 of 5 stars
$1.36
-3.5%
N/A-31.0%$140.10M$446.55M0.001,040Positive News
OFIX
Orthofix Medical
3.0373 of 5 stars
$10.72
-3.6%
$21.50
+100.6%
-29.9%$435.69M$799.49M-2.911,616
SRDX
Surmodics
4.3629 of 5 stars
$29.66
-1.1%
$43.00
+45.0%
-26.8%$428.83M$126.08M-21.34450
ANGO
AngioDynamics
3.9081 of 5 stars
$9.19
-4.1%
$14.00
+52.3%
+55.3%$389.02M$303.91M-9.10760News Coverage
Upcoming Earnings
RMTI
Rockwell Medical
4.1489 of 5 stars
$0.80
-3.1%
$4.00
+401.9%
-46.9%$28.12M$101.49M0.00300Positive News
RSLS
ReShape Lifesciences
0.3801 of 5 stars
$2.38
+0.4%
N/A-99.2%$5.65M$8.01M-0.0150
ABT
Abbott Laboratories
4.9542 of 5 stars
$133.62
-0.6%
$142.61
+6.7%
+26.5%$233.90B$42.34B17.33114,000Trending News
Upcoming Earnings
Analyst Forecast
ISRG
Intuitive Surgical
4.6774 of 5 stars
$534.71
-1.8%
$588.95
+10.1%
+15.3%$195.15B$8.35B78.4015,638Positive News
Analyst Forecast
BSX
Boston Scientific
4.6488 of 5 stars
$103.75
-0.5%
$116.09
+11.9%
+32.8%$154.34B$16.75B75.7353,000Trending News
SYK
Stryker
4.7996 of 5 stars
$392.26
-0.8%
$427.30
+8.9%
+14.7%$150.87B$22.60B53.0153,000Positive News
Analyst Forecast
MDT
Medtronic
4.6142 of 5 stars
$87.73
-0.7%
$97.87
+11.6%
+15.5%$113.36B$33.54B24.2395,000Trending News
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:ARAY) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners